STR-C
STR-C, licence 80041487: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Nature's Sunshine Products of Canada Ltd.
- NPN or DIN-HM
- 80041487
- Status
- Inactive licence
- Licence date
- 8 April 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Albizia julibrissin Durazz.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ziziphus jujuba Source : Graine(s) Extraction ratio : 5:1 Dry plant equivalent : 655 mg | 131.0 mg | Not calculated |
| Wolfiporia extensa Source : Sclerotium Extraction ratio : 5:1 Dry plant equivalent : 655 mg | 131.0 mg | Not calculated |
| Albizia julibrissin Source : Écorce (tige) Extraction ratio : 5:1 Dry plant equivalent : 438 mg | 87.6 mg | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 7.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
Manufactured based on Traditional Chinese Medicine theory.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction, stomach ulcers or excess stomach acid. Consult a health care practitioner if symptoms worsen or persist. Use with caution in patients with diarrhea. Consult a health care practitioner prior to use if you are taking prescription medications. TCM Cautions: Use with caution when there is blazing fire from yin deficiency or excessive heat in the interior. Use with caution in those with cold, yang deficiency, yin deficiency, of deficiency of the spleen and stomach.
- Effets indésirables connus
Hypersensitivity ie: allergy is known to occur in which case discontinue use. May cause drowsiness, exercise caution if driving or operating heavy machinery. May cause dizziness, headache, nausea, epigastric discomfort and/or diarrhea in sensitive individuals.
Source
Official Health Canada record, licence 80041487
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.